Detectable viral load in patients taking HIV therapy associated with poor control of other chronic health problems
Waist circumference and triglycerides: simple measures of increased cardiovascular risk for patients with HIV
Both HIV replication and some types of antiretroviral therapy contribute to cardiovascular risk
Only four US state AIDS Drug Assistance Programmes cover all recommended cardiovascular risk-reduction therapies
Treatment with statins reduces mortality risk for patients taking effective HIV therapy
Ambulatory blood pressure monitoring shows that 15% of HIV patients had undiagnosed high blood pressure
Accelerated hardening of the arteries in patients with HIV; traditional risks the main cause
Marker of cardiovascular disease also associated with bone problems in patients with HIV
